Top Articles

October 9, 2017 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

Sept. 22 was the day that an agreement to sell Miraca Life Sciences (MLS) of Irving, Texas, was announced. Miraca Holdings will sell the anatomic pathology lab company to Avista Capital Partners. As part of the transaction, a new holding company, called Symphony Buyer, will be formed and will own MLS. Miraca Holdings will be

Read More

Can Fee Cuts Be Delayed? Courts Are One Option

Lab industry has 12 weeks to achieve a “delay and fix” agreement with HHS, CMS

CEO SUMMARY: Some lab companies may be prepared to challenge in court the methodology CMS used in setting the requirements of the Protecting Access to Medicare Act of 2014 to conduct a study of private payer market prices for lab tests and use that data to propose new prices for the Part B Clinical Laboratory

Read More

CLFS Talking Points Here Are the Arguments When Commenting on 2018 CLFS Rates

ALL LABORATORY PROFESSIONALS AND pathologists are encouraged to submit comments to CMS before the Oct. 23, as well as send letters to their elected officials in Congress to urge both to delay and to fix the market price study and revise the proposed Clinical Laboratory Fee Schedule for 2018.
Beneficiaries Will Lose Out
Among the most important

Read More

Part B Fee Update Lab Associations Comment on CMS Actions, Lab Fees

ACLA mentions possibility of a legal challenge; NILA predicts many small lab failures, bankruptcies

FOR THE LAB INDUSTRY, THE FEE CUTS proposed in the 2018 Clinical Laboratory Fee Schedule would be even more aggressive than what the federal Centers for Medicare and Medicaid Services had earlier predicted for Medicare Part B.

In the days following the Sept. 22 publication of the proposed fee schedule, major lab industry associations issued statements

Read More

Medicare Update Labs Serving Nursing Homes, Rural Areas to Suffer Most

CLINICAL LABORATORIES WITH A HIGH percentage of Medicare Part B lab test reimbursement are expected to suffer the most under the Part B Clinical Laboratory Fee Schedule (CLFS) cuts that the Centers for Medicare and Medicaid Services proposed Sept. 22.

With the proposed rates scheduled to go into effect on Jan. 1, that leaves just 12

Read More

XIFIN CEO White Analyzes Medicare 2018 Fee Cuts

As most experts predicted, CMS will cut lab test prices deep enough to hurt many labs

CEO SUMMARY: If the draft lab rates that CMS published Sept. 22 for the Clinical Laboratory Fee Schedule for 2018 go into effect Jan. 1 as proposed, then clinical labs will see a cut of 28% in what they get paid for the top 20 most common tests, according to a recent analysis. The rates

Read More

Medicare Update For Top 20 Tests, CMS to Cut Payment by 28% in 2018-2020

Medicare officials move one step closer to destroying beneficiary access to lab tests

ON SEPT. 22, MEDICARE OFFICIALS RELEASED THE DRAFT PRICES for the 2018 Clinical Laboratory Fee Schedule. The bad news for the lab industry is that the fee cuts are deeper than the federal Centers for Medicare and Medicaid Services had predicted earlier.

The price cuts to clinical laboratory test fees will total $670 million in 2018.

Read More

AMA, AHA Join Labs to Request Delay, Fix

22 healthcare associations come together, ask CMS to delay Medicare Part B lab fee cuts

CEO SUMMARY: In what may be a first for the clinical lab industry, the American Medical Association and the American Hospital Association joined with 20 other healthcare associations to ask CMS Administrator Seema Verma to address the problems with the CMS proposal involving Medicare Part B fees. Specifically, the associations asked Verma to delay implementing

Read More

Attention All Lab Professionals: It’s Time to Act!

AT THIS MOMENT, THE ENTIRE CLINICAL LABORATORY INDUSTRY STANDS on the precipice of the most financially disruptive development in the past three decades. On Jan. 1, the federal Centers for Medicare and Medicaid Services will implement deep cuts to the Medicare Part B Clinical Laboratory Fee Schedule.

There is additional unwelcome news. CMS now says that,

Read More

Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

The Dark Report

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

		
test
test
Get web access of The Dark Report for only $19.12 per week.
Get web and tablet access of The Dark Report for only $19.12 per week.
Get digital and print editions of The Dark Report for only $22.97 per week.
Get a hard copy of The Dark Report delivered to your home for only $15.27 per week.
Enter Your Login Credentials
This setting should only be used on your home or work computer.

×